https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-02-01 / Int. J. Oncol. 2002 Feb;20(2):247-53
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-02-01 / Int. J. Oncol. 2002 Feb;20(2):247-532002-02-01 00:00:002020-06-23 09:44:50Generation of dendritic cells from human bone marrow mononuclear cells: advantages for clinical application in comparison to peripheral blood monocyte derived cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-01-30 / Cancer Immunol. Immunother. 2002 Apr;51(2):99-106
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-01-30 / Cancer Immunol. Immunother. 2002 Apr;51(2):99-1062002-01-30 00:00:002019-02-15 08:39:03Immunotherapy of solid cancer using dendritic cells pulsed with the HLA-A24-restricted peptide of carcinoembryonic antigen
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-01-10 / Cancer Immunol. Immunother. 2002 Mar;51(1):45-52
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-01-10 / Cancer Immunol. Immunother. 2002 Mar;51(1):45-522002-01-10 00:00:002019-02-15 08:46:11Vaccination with autologous tumour antigen-pulsed dendritic cells in advanced gynaecological malignancies: clinical and immunological evaluation of a phase I trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-01-07 / Br. J. Cancer 2002 Jan;86(1):151-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-01-07 / Br. J. Cancer 2002 Jan;86(1):151-72002-01-07 00:00:002002-01-07 00:00:00Induction of tumour-specific CD8(+) cytotoxic T lymphocytes by tumour lysate-pulsed autologous dendritic cells in patients with uterine serous papillary cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-01-01 / Med. Oncol. 2002;19(4):213-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-01-01 / Med. Oncol. 2002;19(4):213-82002-01-01 00:00:002019-02-15 08:51:08Dendritic cell vaccines in the treatment of multiple myeloma: advances and limitations
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-01-01 / Int J Gastrointest Cancer 2002;32(1):1-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-01-01 / Int J Gastrointest Cancer 2002;32(1):1-62002-01-01 00:00:002019-02-15 08:52:35The feasibility and safety of immunotherapy with dendritic cells loaded with CEA mRNA following neoadjuvant chemoradiotherapy and resection of pancreatic cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-12-01 / Cancer Res. 2001 Dec;61(23):8513-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-12-01 / Cancer Res. 2001 Dec;61(23):8513-92001-12-01 00:00:002019-02-15 08:53:19Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-10-01 / J. Clin. Endocrinol. Metab. 2001 Oct;86(10):4965-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-10-01 / J. Clin. Endocrinol. Metab. 2001 Oct;86(10):4965-92001-10-01 00:00:002019-02-15 08:53:33Immunotherapy for medullary thyroid carcinoma by dendritic cell vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-09-01 / Cancer Immunol. Immunother. 2001 Sep;50(7):337-44
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-09-01 / Cancer Immunol. Immunother. 2001 Sep;50(7):337-442001-09-01 00:00:002019-02-15 08:47:02Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-07-01 / Semin. Hematol. 2001 Jul;38(3):260-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-07-01 / Semin. Hematol. 2001 Jul;38(3):260-72001-07-01 00:00:002019-02-15 08:51:13Immunotherapy of multiple myeloma
